Literature DB >> 4040603

Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.

R J Kaufman, L C Wasley, A J Spiliotes, S D Gossels, S A Latt, G R Larsen, R M Kay.   

Abstract

Expression of human tissue-type plasminogen activator (t-PA) at high levels has been achieved in Chinese hamster ovary (CHO) cells by cotransfection and subsequent coamplification of the transfected sequences. Expression vectors containing the t-PA cDNA gene and dihydrofolate reductase (DHFR) cDNA gene were cotransfected into CHO DHFR-deficient cells. Transformants expressing DHFR were selected by growth in media lacking nucleosides and contained low numbers of t-PA genes and DHFR genes. Stepwise selection of the DHFR+ transformants in increasing concentrations of methotrexate generated cells which had amplified both DHFR genes and t-PA genes over 100-fold. These cell lines expressed elevated levels of enzymatically active t-PA. To optimize both t-PA sequence amplification and t-PA expression, various modifications of the original procedure were used. These included alterations to the DHFR expression vector, optimization of the molar ratio of t-PA to DHFR sequences in the cotransfection, and modification of the methotrexate resistance selection procedure. The structure of the amplified DNA, its chromosomal location, and its stability during growth in the absence of methotrexate are reported.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040603      PMCID: PMC367294          DOI: 10.1128/mcb.5.7.1750-1759.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates.

Authors:  B R Binder; J Spragg; K F Austen
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Banding patterns and late replication in HeLa cells.

Authors:  R Czaker
Journal:  Humangenetik       Date:  1973-07-20

5.  Analysis of nucleotide sequences at 3' termini of duplex deoxyribonucleic acid with the use of the T4 deoxyribonucleic acid polymerase.

Authors:  P T Englund
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

6.  cDNA and gene nucleotide sequence of porcine plasminogen activator.

Authors:  Y Nagamine; D Pearson; M S Altus; E Reich
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

7.  Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells.

Authors:  F W Alt; R E Kellems; J R Bertino; R T Schimke
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

8.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Separation of plasminogen activators from human plasma and a comparison with activators from human uterine tissue and urine.

Authors:  P Kok
Journal:  Thromb Haemost       Date:  1979-06-30       Impact factor: 5.249

10.  Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexate-resistant Chinese hamster ovary cell line.

Authors:  J H Nunberg; R J Kaufman; R T Schimke; G Urlaub; L A Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

View more
  55 in total

1.  Production of recombinant protein C in serum-containing and serum-free perfusion culture.

Authors:  T Sugiura; H B Maruyama
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

2.  Optimization of cell culture conditions for production of biologically active proteins.

Authors:  S Hosoi; H Miyaji; M Satoh; T Kurimoto; A Mihara; N Fujiyoshi; S Itoh; S Sato
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines.

Authors:  M I Cockett; C R Bebbington; G T Yarranton
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

Review 4.  Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Authors:  R J Kaufman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

5.  Stable expression of recombinant human coagulation factor XIII in protein-free suspension culture of Chinese hamster ovary cells.

Authors:  B H Chun; W G Bang; Y K Park; S K Woo
Journal:  Cytotechnology       Date:  2001-11       Impact factor: 2.058

6.  The gel microdrop secretion assay: Identification of a low productivity subpopulation arising during the production of human antibody in CHO cells.

Authors:  L Hammill; J Welles; G R Carson
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

7.  Evaluation of stable and highly productive gene amplified CHO cell line based on the location of amplified genes.

Authors:  T Yoshikawa; F Nakanishi; S Itami; D Kameoka; T Omasa; Y Katakura; M Kishimoto; K Suga
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

8.  Effects of methotrexate on transfected DNA stability in mammalian cells.

Authors:  M G Pallavicini; P S DeTeresa; C Rosette; J W Gray; F M Wurm
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

9.  Laboratory Scale Production and Purification of a Therapeutic Antibody.

Authors:  Zehra Elgundi; Vicki Sifniotis; Mouhamad Reslan; Esteban Cruz; Veysel Kayser
Journal:  J Vis Exp       Date:  2017-01-24       Impact factor: 1.355

Review 10.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.